- Home
- LGCY vs ZNTL Comparison
LGCY vs ZNTL Comparison
Compare LGCY & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCY
- ZNTL
- Stock Information
- Founded
- LGCY 2009
- ZNTL 2014
- Country
- LGCY United States
- ZNTL United States
- Employees
- LGCY N/A
- ZNTL N/A
- Industry
- LGCY
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- LGCY
- ZNTL Health Care
- Exchange
- LGCY NYSE
- ZNTL Nasdaq
- Market Cap
- LGCY 87.3M
- ZNTL 102.2M
- IPO Year
- LGCY 2024
- ZNTL 2020
- Fundamental
- Price
- LGCY $7.17
- ZNTL $1.23
- Analyst Decision
- LGCY Strong Buy
- ZNTL Buy
- Analyst Count
- LGCY 2
- ZNTL 8
- Target Price
- LGCY $10.65
- ZNTL $8.53
- AVG Volume (30 Days)
- LGCY 42.2K
- ZNTL 752.0K
- Earning Date
- LGCY 05-15-2025
- ZNTL 05-20-2025
- Dividend Yield
- LGCY N/A
- ZNTL N/A
- EPS Growth
- LGCY 44.62
- ZNTL N/A
- EPS
- LGCY 0.58
- ZNTL N/A
- Revenue
- LGCY $52,722,310.00
- ZNTL $67,425,000.00
- Revenue This Year
- LGCY $33.77
- ZNTL N/A
- Revenue Next Year
- LGCY $24.88
- ZNTL N/A
- P/E Ratio
- LGCY $12.16
- ZNTL N/A
- Revenue Growth
- LGCY 32.68
- ZNTL N/A
- 52 Week Low
- LGCY $3.60
- ZNTL $1.01
- 52 Week High
- LGCY $10.37
- ZNTL $13.24
- Technical
- Relative Strength Index (RSI)
- LGCY N/A
- ZNTL 38.08
- Support Level
- LGCY N/A
- ZNTL $1.33
- Resistance Level
- LGCY N/A
- ZNTL $1.32
- Average True Range (ATR)
- LGCY 0.00
- ZNTL 0.10
- MACD
- LGCY 0.00
- ZNTL -0.00
- Stochastic Oscillator
- LGCY 0.00
- ZNTL 8.22
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.